Cargando…

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab

Detalles Bibliográficos
Autores principales:	Park, Jonathan J., Park, Eunsuh, Damsky, William E., Vesely, Matthew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275729/ https://www.ncbi.nlm.nih.gov/pubmed/37332364 http://dx.doi.org/10.1016/j.jdcr.2023.05.004

Ejemplares similares

Treatment of lichen sclerosus and hypertrophic scars with dupilumab
por: Peterson, Danielle M., et al.
Publicado: (2022)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022)

Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib
por: Damsky, William E., et al.
Publicado: (2019)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
por: Ceryn, Justyna, et al.
Publicado: (2021)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

Keratosis lichenoides chronica successfully treated with isotretinoin and methotrexate
por: Li, Alvin W., et al.
Publicado: (2017)

Dupilumab for treatment of severe atopic dermatitis accompanied by lichenoid amyloidosis in adults: Two case reports
por: Zhao, Xue-Qi, et al.
Publicado: (2023)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
por: Peterson, Danielle M., et al.
Publicado: (2021)

Pembrolizumab-Induced Lichenoid Dermatitis in a Patient With Metastatic Cancer of Unknown Primary
por: Sethi, Ashish, et al.
Publicado: (2021)

Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
por: Arnold, Kathryn A., et al.
Publicado: (2018)

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series
por: Chen, Jiaoquan, et al.
Publicado: (2023)

Lichenoid-granulomatous drug reactions to dupilumab: A report of 2 cases
por: Rehan, Zahra, et al.
Publicado: (2023)

The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy
por: Suresh, Raagini, et al.
Publicado: (2018)

De novo case of lichenoid eruption following dupilumab treatment
por: Kim, Tae-Eun, et al.
Publicado: (2021)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
por: Shahriari, Neda, et al.
Publicado: (2023)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Combination treatment of dupilumab with bortezomib in a patient with IgG kappa gammopathy of renal significance, uremic pruritus and chronic lichenoid dermatitis
por: Paolino, Giovanni, et al.
Publicado: (2023)

Dupilumab for the treatment of severe photodermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab
por: McCormick, Benjamin Joseph, et al.
Publicado: (2023)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
por: Edmonds, Nicole, et al.
Publicado: (2021)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
por: Igelman, Sean J., et al.
Publicado: (2020)

Lichenoid contact dermatitis secondary to methylisothiazolinone (MI)
por: Raymond, James, et al.
Publicado: (2016)

Annular Lichenoid Dermatitis (of Youth)
por: Annessi, Giorgio, et al.
Publicado: (2022)

Lichenoid Keratosis: A Clinical Trap without Secrets for Reflectance Confocal Microscopy
por: Mazzilli, Sara, et al.
Publicado: (2020)

Review of dupilumab-associated inflammatory arthritis: An approach to clinical analysis and management
por: Jay, Ryan, et al.
Publicado: (2022)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)

Targetoid clinical morphology as a diagnostic clue of the lichenoid histopathologic subtype of pigmented purpuric dermatosis
por: Ahmed, Amara, et al.
Publicado: (2021)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
por: Wu, Chenyu, et al.
Publicado: (2023)

Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
por: Luo, Nana, et al.
Publicado: (2022)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
por: Steinhoff, M., et al.
Publicado: (2021)

Dupilumab for atopic dermatitis
Publicado: (2019)

A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab
por: Sugano, Teppei, et al.
Publicado: (2018)

Pityriasis lichenoides chronica–like drug eruption developing during pembrolizumab treatment for metastatic melanoma
por: Mutgi, Krishna A.J., et al.
Publicado: (2016)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Dupilumab in HIV-positive patients: A case series report of 4 patients
por: Alawadhi, Ameen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_33gi7o8sm3c08scg5devcvi2bu